Raia Drogasil S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020
October 28, 2020 at 06:20 am IST
Share
Raia Drogasil S.A. Announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was BRL 5,093.453 million compared to BRL 4,601.641 million a year ago. Net income was BRL 154.725 million compared to BRL 459.341 million a year ago. Basic earnings per share was BRL 0.4694 compared to BRL 1.39374 a year ago. Diluted earnings per share was BRL 0.46732 compared to BRL 1.39482 a year ago. For the nine months, total revenue was BRL 14,513.099 million compared to BRL 12,780.486 million a year ago. Net income was BRL 322.722 million compared to BRL 686.285 million a year ago. Basic earnings per share was BRL 0.97906 compared to BRL 2.08338 a year ago. Diluted earnings per share was BRL 0.97472 compared to BRL 2.07784 a year ago.
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
RAIA DROGASIL S.A. 
